EyePoint (EYPT) Enterprise Value (2010 - 2026)
EyePoint (EYPT) reported Enterprise Value of -$222.5 million for Q1 2026, up 30.06% on a YoY basis from -$171.1 million in Q1 2025, and up 27.29% sequentially from -$306.1 million in Q4 2025.
EyePoint (EYPT) Enterprise Value (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Enterprise Value data on file, last reported at -$222.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 30.06% year-over-year to -$222.5 million; the trailing twelve-month figure through Mar 2026 stood at -$222.5 million (up 30.06% YoY), and the FY2025 full-year result was -$306.1 million, up 17.48% from the prior year.
- Enterprise Value rose to -$222.5 million in Q1 2026, from -$306.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$122.5 million in Q1 2023 to a low of -$370.9 million in Q4 2024.
- A 5-year average of -$229.8 million and a median of -$222.5 million in 2026 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 35.81% in 2023 and tumbled 144.44% in 2024, its largest moves.
- Tracing EYPT's Enterprise Value over 5 years: stood at -$144.6 million in 2022, then plunged by 129.0% to -$331.0 million in 2023, then declined by 12.04% to -$370.9 million in 2024, then increased by 17.48% to -$306.1 million in 2025, then gained by 27.29% to -$222.5 million in 2026.
- Business Quant data shows EYPT's Enterprise Value at -$222.5 million in Q1 2026, -$306.1 million in Q4 2025, and -$204.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -222.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -222.55 Mn |
| Dec 31, 2025 | -306.09 Mn |
| Sep 30, 2025 | -204.02 Mn |
| Jun 30, 2025 | -255.73 Mn |
| Mar 31, 2025 | -318.19 Mn |
| Dec 31, 2024 | -370.91 Mn |
| Sep 30, 2024 | -253.79 Mn |
| Jun 30, 2024 | -280.25 Mn |
| Mar 31, 2024 | -299.35 Mn |
| Dec 31, 2023 | -331.05 Mn |
| Sep 30, 2023 | -136.01 Mn |
| Jun 30, 2023 | -142.50 Mn |
| Mar 31, 2023 | -122.47 Mn |
| Dec 31, 2022 | -144.56 Mn |
| Sep 30, 2022 | -157.26 Mn |
| Jun 30, 2022 | -171.17 Mn |
| Mar 31, 2022 | -190.78 Mn |
| Dec 31, 2021 | -211.56 Mn |
| Sep 30, 2021 | -119.71 Mn |
| Jun 30, 2021 | -127.60 Mn |